RxDoctor Payments Data

Steven Moore, MD

Neuropathology · Iowa City, IANPI 1174511935

Payments from drug & device makers

$1,106,411in general payments, 2019–2025

Across 60 payments — averaging $18,440 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Sarepta Therapeutics, Inc.$1.1M
  • Vertex$8K

What the payments were for

  • Consulting fees$8,25099%
  • Food & beverage$851%

General payments by program year

21
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Sarepta Therapeutics, Inc.56$1,098,161
Vertex4$8,250

How this compares

Too few neuropathology providers in Iowato place this figure against a meaningful peer group, so we don't.

Medicare billing

Part B allowed, 2024
$9,928
Medicare patients
48
Services billed
298

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other neuropathology in Iowa City

Where these figures come from

Is this you, or does something look wrong? →